triazolam has been researched along with Drug Abuse, Intravenous in 2 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Green, S | 1 |
| Goldberg, D | 1 |
| Frischer, M | 1 |
| McKeganey, N | 1 |
| Haiart, DC | 1 |
| Andrade, B | 1 |
| Murie, JA | 1 |
2 other studies available for triazolam and Drug Abuse, Intravenous
| Article | Year |
|---|---|
Triazolam as a substance of abuse among injecting drug users.
Topics: Comorbidity; Female; Humans; Male; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; | 1992 |
Gas gangrene following intra-arterial injection of oral medication in a drug abuser.
Topics: Accidents; Adult; Animals; Cyclizine; Femoral Artery; Gas Gangrene; Humans; Injections, Intra-Arteri | 1992 |